Fennec Pharmaceuticals (FENC) EBIAT (2016 - 2025)
Historic EBIAT for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$638000.0.
- Fennec Pharmaceuticals' EBIAT rose 8887.53% to -$638000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 51253.31%. This contributed to the annual value of -$436000.0 for FY2024, which is 9728.26% up from last year.
- Per Fennec Pharmaceuticals' latest filing, its EBIAT stood at -$638000.0 for Q3 2025, which was up 8887.53% from -$3.2 million recorded in Q2 2025.
- Fennec Pharmaceuticals' 5-year EBIAT high stood at $12.8 million for Q1 2024, and its period low was -$10.3 million during Q4 2022.
- Its 5-year average for EBIAT is -$3.4 million, with a median of -$4.1 million in 2021.
- Within the past 5 years, the most significant YoY rise in Fennec Pharmaceuticals' EBIAT was 31211.17% (2024), while the steepest drop was 20717.73% (2024).
- Quarter analysis of 5 years shows Fennec Pharmaceuticals' EBIAT stood at -$4.2 million in 2021, then tumbled by 145.15% to -$10.3 million in 2022, then soared by 74.04% to -$2.7 million in 2023, then grew by 25.99% to -$2.0 million in 2024, then skyrocketed by 67.86% to -$638000.0 in 2025.
- Its EBIAT was -$638000.0 in Q3 2025, compared to -$3.2 million in Q2 2025 and -$1.2 million in Q1 2025.